Mounjaro®
Starting from £179.99/mo
Start journey Learn moreEach Mounjaro KwikPen contains 3 ml of solution, pre-filled and ready to use. That 3 ml holds four weekly doses, so one pen covers a full four-week supply at whatever strength you have been prescribed. The medicine is a prescription-only treatment requiring clinical assessment before a prescriber decides whether it is suitable for you. Understanding the pen's volume helps you track your supply and spot any delivery or administration concerns early — which is exactly what this page covers, drawing on the Mounjaro Summary of Product Characteristics on the eMC and NHS guidance on tirzepatide.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Mounjaro SmPC (the authoritative product document filed with the MHRA and published on the eMC) confirms that each KwikPen is pre-filled with 3 ml of a clear, colourless-to-slightly-yellow solution. With four weekly injections per pen, basic arithmetic puts each individual injection at 0.75 ml. You will never need to calculate or draw up that volume yourself; the pen's internal mechanism dispenses a fixed, pre-set amount each time you press the injection button. That design removes any user measurement step entirely, which is one reason tirzepatide was approved in this format.
The 3 ml total is constant across all six UK-licensed strengths. A 2.5 mg starter pen and a 15 mg maintenance pen are physically the same size and contain the same liquid volume, only the concentration of tirzepatide changes. This matters if you are checking whether a pen you have received looks right: the size alone tells you nothing about the dose inside, so always read the label carefully. If something looks wrong with a pen, the frequently asked questions section covers what to do before your next injection.
The NHS guidance on tirzepatide notes that the pen should be kept refrigerated between 2°C and 8°C. Many people find it easiest to store their pen on the shelf inside the fridge door, away from the freezer compartment, cold enough to be within range, accessible enough to remember. For precise storage windows once removed from the fridge, the patient information leaflet that arrives with every pen is the definitive reference; storage windows do vary and the SmPC figure is the one to follow.
Knowing that a pen contains exactly four doses makes supply planning straightforward. If you inject once a week, one pen lasts four weeks. There is no partial dose left over, no guesswork about how much remains. The pen itself has a dose counter that counts down from four to zero, and a visual indicator shows when it is empty. Understanding the number of injections in each Mounjaro pen in this way means you can order a repeat in good time rather than running short.
For anyone transferring to a higher dose, the pen format stays the same: 3 ml, four doses, same weekly rhythm. What changes is the concentration, more milligrams of tirzepatide are dissolved into that same 0.75 ml per injection. A prescriber will advise when a dose increase is appropriate; it is not something to self-initiate. If you are thinking about how many pens your full treatment course might involve, the answer depends on how long you are on each dose tier before titrating upward, which varies between patients.
One practical note: the device locks permanently after the fourth dose and should not be reused. Safe disposal matters. A 1-litre sharps container is the correct way to dispose of used pens; local council or pharmacy-based sharps collection services will accept sealed containers.
Tirzepatide is a dual GIP and GLP-1 receptor agonist, it activates two gut-hormone pathways involved in appetite regulation and blood-sugar control, and it slows gastric emptying to increase fullness after eating. This mechanism underpinned the SURMOUNT-1 trial, which involved 2,539 adults and found that average body-weight reduction reached around 20–21% at the 15 mg dose over 72 weeks. Those results are behind the interest in how Mounjaro works as a weight-management treatment in clinical practice today.
Because the medicine works cumulatively over weeks, consistent weekly injections at the right dose matter. The pre-filled, fixed-volume pen format supports that consistency: there is no syringe to fill, no concentration to dilute, and no ambiguity about how much has been injected. Mounjaro is injected once weekly, on the same day each week where possible, into the abdomen, thigh or upper arm, with the injection site rotated each time. The full injection guide covers technique, site selection and what to do if you miss a dose.
Questions about how many clicks a Mounjaro pen makes during injection often come up alongside volume questions, the audible click indicates the dose has been delivered, which is a separate (and equally practical) thing to understand before you use one for the first time.
The 3 ml pen format is the same whether you are starting at 2.5 mg or maintaining at a higher dose, but the clinical picture around each pen is different. Treatment begins at 2.5 mg because that first pen's primary job is letting your body adjust, not yet delivering full therapeutic effect. Titration typically moves upward in four-week steps under prescriber guidance.
NICE's appraisal of tirzepatide (TA1026) sets out the criteria under which it is recommended, and a prescriber will weigh BMI, comorbidities and clinical history before approving any prescription. If you want to understand what reaching a maintenance dose actually leads to over time, what happens when you reach your target weight on Mounjaro is a question worth exploring. For those weighing up the cost side of treatment, the Mounjaro pricing guide explains what a private prescription typically includes and what to look for when comparing providers.
If you are considering whether Mounjaro is right for you, a prescriber at nume reviews every consultation personally, the same day it is submitted. Speak to our prescribers through the free consultation; there is no obligation, and clinical suitability is assessed before anything else.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.